| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 9821 |
| 1 | INTERFERON BETA-1A | 9389 |
| 2 | DIMETHYL FUMARATE | 5766 |
| 3 | DALFAMPRIDINE | 3136 |
| 4 | OCRELIZUMAB | 3123 |
| 5 | GLATIRAMER ACETATE | 3103 |
| 6 | FINGOLIMOD HCL | 2433 |
| 7 | BACLOFEN | 2347 |
| 8 | ERGOCALCIFEROL | 2246 |
| 9 | TERIFLUNOMIDE | 2224 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLATIRAMER ACETATE INJECTION | 599 | 0.1272 |
| 1 | DIROXIMEL FUMARATE | 1122 | 0.0927 |
| 2 | ERGOCALCIFEROL | 2246 | 0.0755 |
| 3 | FINGOLIMOD HYDROCHLORIDE | 341 | 0.0669 |
| 4 | INTERFERON BETA-1B | 1166 | 0.0611 |
| 5 | SIPONIMOD | 489 | 0.0548 |
| 6 | NATALIZUMAB | 9821 | 0.0542 |
| 7 | GLATIRAMER ACETATE | 3103 | 0.0521 |
| 8 | OCRELIZUMAB | 3123 | 0.0498 |
| 9 | TERIFLUNOMIDE | 2224 | 0.0493 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 9959 |
| 1 | Interferon beta [EPC] | 9929 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 5067 |
| 3 | Potassium Channel Blocker [EPC] | 3136 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2871 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 2350 |
| 6 | Provitamin D2 Compound [EPC] | 2246 |
| 7 | Pyrimidine Synthesis Inhibitor [EPC] | 2224 |
| 8 | Benzodiazepine [EPC] | 2137 |
| 9 | Corticosteroid [EPC] | 1633 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 9959 | 0.1144 |
| 1 | Provitamin D2 Compound [EPC] | 2246 | 0.0755 |
| 2 | Interleukin-5 Antagonist [EPC] | 44 | 0.0640 |
| 3 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 772 | 0.0556 |
| 4 | Interferon beta [EPC] | 9929 | 0.0516 |
| 5 | Pyrimidine Synthesis Inhibitor [EPC] | 2224 | 0.0493 |
| 6 | Potassium Channel Blocker [EPC] | 3136 | 0.0438 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 90 | 0.0434 |
| 8 | Polymyxin-class Antibacterial [EPC] | 2 | 0.0274 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 2350 | 0.0263 |